Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 127Colonic Neoplasms 71Rectal Neoplasms 56Neoplasm Metastasis 22Pancreatic Neoplasms 21Stomach Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia 11Carcinoma, Hepatocellular 11Neoplasms 10Lymphoma 10Burkitt Lymphoma 8Adenocarcinoma Of Esophagus 8Cholangiocarcinoma 6Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Esophageal Neoplasms 5Leukemia, Biphenotypic, Acute 4Intestinal Neoplasms 4Gastrointestinal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Digestive System Neoplasms 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Gallbladder Neoplasms 3Biliary Tract Neoplasms 3Rectal Diseases 2Neurotoxicity Syndromes 2

Interventions

napabucasin 2linifanib 1Vaccines 1Sorafenib 1Radiofrequency Ablation 1Papillomavirus Vaccines 1Leucovorin 1Irinotecan 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gemcitabine 1Fluorouracil 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms, Glandular and Epithelial × Leucovorin × Clear all
NCT02753127 2023-11-15

CanStem303C

Sumitomo Pharma America, Inc.

Phase 3 Completed
1,253 enrolled 18 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡